Humacyte, Inc. - Common Stock, par value $0.0001 per share (HUMA)

CUSIP: 44486Q103

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class
Equity / Common Stock, par value $0.0001 per share
Total 13F shares
23,275,197
Total 13F value
$72,382,833
Holder snapshot 6 visible 7 signals
Share change
+5,471,916
Put/Call ratio
292%
SEC-reported price per share
$3.11
Number of holders
95
Value change
+$17,071,734
Number of buys
45
Open additional details 1 more signal available
Number of sells
41
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
269,769,473

Security key

44486Q103

Report period

Q1 2024

Institutions

95

Top holders

10

HUMA full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2024 Previous quarter: Q4 2023 Humacyte, Inc. SEC filings Humacyte, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FRESENIUS MEDICAL CARE HO...
Disclosed value leader
FRESENIUS MEDICAL CARE HO...
Comparable rows
15/15
Latest evidence
31 Dec 2023
3/4/5 13F Lead comparable stake: 6.8% Showing 1-6 of 15 holder rows.

Quick read

FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ leads the comparable SEC ownership view at 6.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.
Comparable ownership Top 5
FRESENIUS MEDICAL CARE HOLDINGS I... 6.8%
BlackRock Finance, Inc. 1.8%
VANGUARD GROUP INC 1.2%
GEODE CAPITAL MANAGEMENT, LLC 0.49%
MILLENNIUM MANAGEMENT LLC 0.48%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/
3/4/5
Former 10% Shareholder
3/4/5
6.8%
$21,792,154
18,312,735 shares
 — 26 Aug 2021
BlackRock Finance, Inc.
13F
Company
13F
1.8%
$13,913,980
4,899,289 shares
 — 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
1.2%
$8,870,075
3,123,266 shares
 — 31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.49%
$3,765,333
1,325,675 shares
 — 31 Dec 2023
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
0.48%
$3,678,839
1,295,366 shares
 — 31 Dec 2023
STATE STREET CORP
13F
Company
13F
0.43%
$3,273,926
1,152,791 shares
 — 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
95
Shares
23,275,197
Rows available
95
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
87
Q1 2024 holders
95
Holder diff
8
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .